Imprint Provider identification according to § 5, 6 DDG NMI Natural and Medical Sciences Institute at the University of Tübingen Markwiesenstrasse 55 72770 Reutlingen Foundation directory : Az.: RPT01

Pharma & Biotech The pharmaceutical industry is characterized by dynamic developments and considerable progress in bio-medical research. The industry is characterized by ever-increasing competition wi

Services Dr. Nicole Schneiderhan-Marra Head of Pharma & Biotech +49 7121 51530-815 E-Mail anzeigen Dr. Markus Templin Group Leader Cellular & Molecular Biology +49 7121 51530-828 E-Mail anzeigen Dr. J

Physicochemical Analysis Dr. Hanna Hartmann Head of Biomedicine & Material Sciences Group Leader Regenerative Biomaterials +49 7121 51530-872 E-Mail anzeigen Dr. Xin Xiong Group Leader Biofunctionaliz

Neuronal plasticity within the basolateral amygdala (BLA) is fundamental for fear learning. Metaplasticity, the regulation of plasticity states, has emerged as a key mechanism mediating the subsequent

Young researchers in Reutlingen: A group of students from Albstadt-Sigmaringen University spent the last three days at the NMI and gained an insight into the work of the researchers. Young researchers

Data privacy Data protection We are pleased about your visit to our website. In the following, we will inform you about which personal data we collect and what happens to this data when you visit our

History Foundation and development of the NMI The state needs more application orientation The impetus for founding the NMI came in 1983 from Dr. Günter Hoff, head of research in the "New Technologies

The aim of the project is to identify early biological indicators to predict the effects of non-genotoxic carcinogens

Non-invasive diagnostic approach to determine patient risk from tumor metastasis based on circulating tumor cells. Individual therapy success and survival rate of tumor patients depend to a large exte